Drug Profile
Research programme: corticosteroid derivatives - Aqualis
Alternative Names: CP-4112; CP-4114; CP-4166Latest Information Update: 07 Nov 2013
Price :
$50
*
At a glance
- Originator Clavis Pharma
- Developer Aqualis
- Class Fluorinated steroids; Pregnadienetriols
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 09 Oct 2013 Clavis Pharma is now called Aqualis
- 29 Aug 2013 Discontinued - Preclinical for Inflammation in Norway (unspecified route)
- 16 Mar 2009 Preclinical development is ongoing